Harbin Medisan Pharmaceutical Co Ltd (002900) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Harbin Medisan Pharmaceutical Co Ltd (002900) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.53 Million ≈ $-2.27 Million USD) by net assets (CN¥1.90 Billion ≈ $278.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002900 market cap overview for the company's overall valuation and market capitalisation.

Harbin Medisan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Harbin Medisan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Harbin Medisan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Medisan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Harbin Medisan Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Nanjing Hicin Pharmaceutical Co Ltd SHE:300584	-0.006x
West Coast Paper Mills Limited NSE:WSTCSTPAPR	0.072x
Harbin Jiuzhou Electrical Co Ltd SHE:300040	0.108x
Tilray Inc NASDAQ:TLRY	-0.023x
Anhui Ankai Automobile Co Ltd SHE:000868	0.002x
Zhewen Pictures Group Co Ltd SHG:601599	0.048x
Shanghai Karon Eco-Valve Manufacturing Co. Ltd. SHE:301151	0.167x
Man Infraconstruction Limited NSE:MANINFRA	0.007x

Annual Cash Flow Conversion Efficiency for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Medisan Pharmaceutical Co Ltd from 2012 to 2024. View today's stock price for Harbin Medisan Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.16 Billion ≈ $316.68 Million	CN¥30.69 Million ≈ $4.49 Million	0.014x	-14.66%
2023-12-31	CN¥2.15 Billion ≈ $314.35 Million	CN¥35.69 Million ≈ $5.22 Million	0.017x	-76.43%
2022-12-31	CN¥2.05 Billion ≈ $300.27 Million	CN¥144.64 Million ≈ $21.17 Million	0.070x	+1290.28%
2021-12-31	CN¥2.12 Billion ≈ $309.71 Million	CN¥-12.53 Million ≈ $-1.83 Million	-0.006x	-135.40%
2020-12-31	CN¥1.79 Billion ≈ $262.16 Million	CN¥-4.51 Million ≈ $-659.52K	-0.003x	-101.46%
2019-12-31	CN¥1.85 Billion ≈ $270.96 Million	CN¥320.14 Million ≈ $46.85 Million	0.173x	+16.45%
2018-12-31	CN¥1.97 Billion ≈ $288.24 Million	CN¥292.46 Million ≈ $42.80 Million	0.148x	+21.92%
2017-12-31	CN¥1.83 Billion ≈ $268.51 Million	CN¥223.46 Million ≈ $32.70 Million	0.122x	-57.43%
2016-12-31	CN¥808.17 Million ≈ $118.26 Million	CN¥231.18 Million ≈ $33.83 Million	0.286x	+3.68%
2015-12-31	CN¥727.97 Million ≈ $106.53 Million	CN¥200.85 Million ≈ $29.39 Million	0.276x	+44.50%
2014-12-31	CN¥609.16 Million ≈ $89.14 Million	CN¥116.31 Million ≈ $17.02 Million	0.191x	-58.28%
2013-12-31	CN¥365.13 Million ≈ $53.43 Million	CN¥167.10 Million ≈ $24.45 Million	0.458x	+27.29%
2012-12-31	CN¥342.72 Million ≈ $50.15 Million	CN¥123.22 Million ≈ $18.03 Million	0.360x	--

About Harbin Medisan Pharmaceutical Co Ltd

SHE:002900 China Drug Manufacturers - Specialty & Generic

Market Cap

$548.57 Million

CN¥3.75 Billion CNY

Market Cap Rank

#11859 Global

#3406 in China

Share Price

CN¥11.85

Change (1 day)

+0.25%

52-Week Range

CN¥9.18 - CN¥15.63

All Time High

CN¥32.63